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Electrospun poly-ƹ-caprolactone/zinc oxide (PCL/ZnO) nanocomposite scaffolds were reported for 
tissue engineering and wound healing applications. Wound coverage materials should have good 
barrier property against invading microbes. Since wound coverage materials and tissue engineering 
scaffolds are in direct contact with blood, such materials should be blood compatible. Thus, blood 
compatibility of the fabricated scaffolds has been tested by RBC and WBC aggregation studies. 
Hemolysis assay and platelet activation study were also carried out. This study is promising in the 
sense that the fabricated scaffolds showed excellent microbial barrier property and were highly 
compatible with RBC and WBC and did not induce haemolysis. However, need to be vigilant regarding 
the possible platelet aggregation that can happen at higher concentrations of ZnO nanoparticles.
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Изучены полученные электропрядением нанокомпозитные скаффолды поли-ƹ-капролактон/
оксид цинка (PCL/ZnO), которые могут быть использованы в тканевой инженерии и при 
лечении ран. Материалы раневых покрытий должны иметь высокие противомикробные 
барьерные свойства. Поскольку материалы раневых покрытий и тканеинженерные скаффолды 
находятся в прямом контакте с кровью, такие материалы должны быть кровесовместимыми. 
Поэтому была исследована совместимость полученных скаффолдов с кровью путем оценки 
агрегации эритроцитов и лейкоцитов. Также была проведена гемолизная проба и исследование 
активации тромбоцитов. Исследование показало хорошие противомикробные барьерные 
свойства и высокую совместимость скаффолдов с эритроцитами и лейкоцитами, а также 
отсутствие индукции гемолиза. Однако при высоких концентрациях наночастиц ZnO может 
отмечаться агрегация тромбоцитов.
Ключевые слова: поли-ƹ-капролактон, оксид цинка, тканевая инженерия, скаффолды, 
кровесовместимость, противомикробные барьерные свойства.
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Introduction
Electrospinning technology, which can easily 
mass-produce thin nano to submicron fibrous 
membranes with good conformability, could 
offer a solution to fabricate tissue engineering 
scaffolds and skin substitutes (Recek et al., 
2016). Electrospun nanofibers resemble the native 
topographical features of the natural extracellular 
matrix and may promote natural functions of 
the cell in a biomimetic fashion. Electrospun 
membranes have various properties that make 
them suitable as skin substitute materials such 
as high oxygen permeability, variable pore 
size, a high surface area to volume ratio and 
morphological similarity to the extracellular 
matrix (ECM) (Smith et al., 2004; Zahedi et al., 
2010). Various natural and synthetic polymers/
polymer blends have been electrospun into 
nanofibers to generate potential wound dressing 
materials. The ability to incorporate a variety 
of bioactive molecules (such as antimicrobials, 
anti-inflammatory agents) into the nanofibers can 
increase the desirable wound healing (and wound 
dressing) properties (Augustine et al., 2016b).
Recently, poly (ε-caprolactone) (PCL) has 
drawn a lot of attention in biomedical applications 
(Nandagopal et al., 2016). PCL has several 
advantages including low cost, biocompatibility, 
and biodegradability (Eldsäter et al., 2000). 
PCL has been suggested in applications such as 
drug delivery system (Zhong et al., 2001; Allen 
et al., 2000), tissue-engineered skin (plain film) 
and scaffolds for supporting fibroblasts and 
osteoblasts growth (Hutmacher et al., 2001), etc.
Electrospun PCL scaffolds containing 
various metal oxide nanoparticles were fabricated 
and extensively studied for the physicochemical 
properties and cytocompatibility both in vitro and 
in vivo (Augustine et al., 2017b; Augustine et al., 
2017c). As the concentration of ZnO nanoparticles 
has increased, both fiber diameter and fiber 
morphology were varied greatly (Augustine 
et al., 2014c). ZnO nanoparticles incorporated 
scaffolds have shown superior mechanical 
properties than the neat PCL ones. Then, these 
nanocomposite membranes have been evaluated 
for the antibacterial property, cell proliferation, 
cytocompatibility and the in vitro degradation. 
Incorporation of ZnO nanoparticles in electrospun 
PCL membranes imparted antibacterial property 
to the scaffolds (Augustine et al., 2014c). The 
fabricated PCL/ZnO nanocomposite membranes 
have shown enhanced biodegradation than the 
neat PCL membranes (Augustine et al., 2016a). 
Presence of ZnO nanoparticles promoted wound 
healing by enhanced angiogenesis, cell adhesion, 
migration and proliferation (Augustine et al., 
2014a, b).
In addition to the detailed antibacterial, 
cytocompatibility and wound healing studies, it 
is essential to understand the ability of PCL/ZnO 
nanocomposite scaffolds to prevent the entry of 
microbes to the wound. Thus, the microbial barrier 
properties of PCL/ZnO nanocomposite scaffolds 
was evaluated in the present study. Moreover, the 
blood cell aggregation and hemolysis due to PCL/
ZnO scaffolds is very important to be explored. 
Hence, the aggregation behavior of human blood 
cells due to the effect of PCL/ZnO nanocomposite 
scaffolds was addressed in this study. Hemolysis 
due to these scaffolds were also evaluated.
Materials and methods
Fabrication of scaffolds
Electrospun PCL/ZnO nanocomposite 
scaffolds were fabricated by our reported 
procedure (Augustine et al., 2014c). PCL scaffolds 
containing 0.5 % w/w ZnO nanoparticles,  1 % w/w 
ZnO nanoparticles, 2 % w/w ZnO nanoparticles, 
4 % w/w ZnO nanoparticles and 6 % w/w ZnO 
nanoparticles were fabricated and denoted by the 
codes PCL/ZnO-0.5, PCL/ZnO-1, PCL/ZnO-2, 
PCL/ZnO-4, and PCL/ZnO-6, respectively. The 
scaffolds were characterized for morphology by 
– 229 –
Robin Augustine, Nandakumar Kalarikkal… Microbial Barrier Property and Blood Compatibility Studies of Electrospun…
JEOL JSM 6390 scanning electron microscopy. 
A Philips XL-30 FEG Scanning Electron 
Microscope was used to analyze electrospun PCL 
samples at higher resolution to visualize ZnO 
nanoparticles in the fibers. PCL and ZnO (about 
60 nm) nanoparticles used in this study were 
purchased from Sigma Aldrich, India. 
Determination of microbial barrier  
property (MBP)
To measure the Microbial Barrier Property 
(MBP) of electrospun PCL/ZnO nanocomposite 
scaffolds, our previously reported procedure 
was used (Augustine et al., 2015). Sample 
bottles with 2 cm mouth diameter was used for 
this study. A hole with the diameter of 2 cm 
were made on the caps of the bottle. The bottles 
and their caps were sterilized by autoclaving at 
121 ºC and 15 lbs pressure for 15 minutes. All 
the membranes were dipped in 70 % alcohol and 
UV irradiated for 15 minutes. Sterilized media 
(Peptone water, Himedia, India) was poured 
into the bottle and placed in a laminar air flow 
system to get cooled. After cooled to room 
temperature, the holes on the caps were covered 
with the samples (neat PCL and PCL/ZnO 
nanocomposite scaffolds). A positive control was 
also maintained which was a standard wound 
coverage material (Cipla FirstAid, Cipla, India). 
Then, the bottle-membrane assemblies were 
kept in an open hall with a relative humidity of 
70 % and a temperature of 28 ºC. After 24 hours 
of incubation, the bottle-membrane assemblies 
were placed in laminar air flow system. After 
removing cap and the membrane, 100 microliter 
of the peptone water from the bottles were poured 
on the centre of Mueller Hinton agar (Himedia, 
India) plates and spread plated in triplicates. 
The plates were incubated for overnight. Colony 
Forming Units (CFUs) were counted and the 
Microbial Barrier Property (MBP) was measured 
using the equation (1).
( )
ontrolPositive c
 X est sampleontrol - TPositive c
MBP (%)
100=  
 
. (1)
All the experiments were carried out in 
triplicates and expressed as mean ± SD.
Blood compatibility studies
There are two important tests which are used 
to evaluate the blood compatibility of materials, 
blood cell aggregation and hemolysis tests. 
Both blood aggregation study and hemolysis 
assay were carried out according to the reported 
protocol (Augustine et al., 2017a). Human blood 
sample was collected from healthy volunteers 
in a tube containing 3.8 % sodium citrate at 9:1 
ratio (blood : anticoagulant). The collected blood 
was used for both aggregation and hemolysis 
studies. Electrospun membranes of neat PCL 
and those containing various amount of ZnO 
nanoparticles were used for blood compatibility 
studies. Normal saline and Polyethylenimine 
(PEI, Alfa Aesar, USA) were used as the negative 
and positive controls, respectively. Both neat 
PCL and PCL/ZnO nanocomposite membranes 
were cut into 1 x 1 cm2 size and sterilized by 
dipping in 70 % alcohol for 20 minutes and UV 
irradiation for 20 minutes. The samples were then 
kept for overnight incubation in 1 mL PBS (Life 
Technologies, India) solution and these solutions 
were used for hemolysis assay, RBC aggregation, 
WBC aggregation and platelet activation.
Blood cell aggregation study
To perform RBC aggregation studies, the 
blood was centrifuged at 700 rpm for 10 min to 
separate the RBC from the blood plasma. This 
separated layer was washed twice with saline 
and diluted with PBS (1:4). 2 mL of this diluted 
RBC was added to the PBS solution in which the 
membranes were kept previously for overnight 
incubation, and then kept at 37 ºC for 20 minutes. 
The diluted RBC was also incubated along with 
negative and positive control.
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The WBC compatibility study was done 
with anti-coagulated blood (1 mL) overlaid with 
histopaque (1 mL, Sigma Aldrich, India) in order 
to make two separate layers and was centrifuged 
for 15 minutes at 800 rpm at room temperature. 
RBC goes to the bottom of the tube, histopaque 
come at the middle and WBC above the histopaque 
layer. The top layer will be the platelet layer. The 
collected WBC was incubated with PBS solution 
in which the membranes were kept previously 
for overnight incubation, for 20 minutes at 
37 °C. Similar procedure was carried out for the 
incubation of WBC with the positive (PEI) and 
negative (Normal saline) controls.
After incubation, both the cells were isolated 
by centrifugation, resuspended in PBS and 
examined on wet mounted slides and the images 
were captured by phase contrast microscope 
(Leica DMIRB).
Platelet activation
Platelets were isolated from anti-coagulated 
blood (1 mL) overlaid with histopaque (1 mL) 
in order to separate blood cells as separate 
layers and was centrifuged for 15 minutes at 
800 rpm at room temperature. The platelets 
were separated as the topmost layer above WBC 
layer. The collected platelets were incubated 
with PBS solution in which the membranes were 
kept previously for overnight incubation, for 20 
minutes at 37 ºC. Similar procedure was carried 
out for the incubation of platelets with the positive 
(PEI) and negative controls (Normal saline).
Hemolysis assay
Hemolysis assay was carried out on PCL 
membranes and PCL membranes containing 
various concentrations of ZnO nanoparticles. In 
brief, 100 µl of the separated blood was diluted 
with 800 µl saline. To this diluted blood, 100 µl 
of each PBS solution in which the membranes 
were kept previously for overnight incubation, was 
added. Here, normal saline was used as negative 
control and distilled water as positive control. The 
samples were incubated for 30 minutes at 37 ºC 
and were centrifuged at 700 rpm for 5 min. The 
optical density (OD) was measured at 541 nm using 
a UV–Vis spectrophotometer (Shimadzu double-
beam spectrophotometer-Model 1700). Percentage 
of hemolysis was calculated from equation (2).
After incubation, both the cells were isolated by centrifugation, resuspended in PBS and 
examined on wet mounted slides and the images were captured by phase contrast microscope 
(Leica DMIRB). 
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Results and discussion
Fiber morphology
Presence of ZnO nanoparticles of various 
concentration ranges from 0.5 % w/w to 6 % w/w 
in PCL fibers, significantly changed the fiber 
morphology provided other experimental 
parameters remained constant. Fig. 1A shows 
the SEM image of neat PCL membrane. From 
the figure it is clear that the surface of individual 
fibers are smooth. It can be observed from the 
SEM micrographs that both PCL and PCL/ZnO 
nanocomposite membranes were highly porous 
in morphology. Pore spacing measurement from 
SEM micrographs has shown that all the fabricated 
membranes had an average pore spacing of 
11.4 ± 3.2 µm. Fig. 1B shows the SEM micrographs 
of PCL/ZnO nanocomposite membranes 
containing 1 % w/w of ZnO nanoparticles. Here, 
fiber morphology was almost uniform with micro 
and nanofibrous structures. Fig. 1C shows the 
presence of well dispersed ZnO nanoparticles on 
individual fibers. There were no agglomerations 
of ZnO nanoparticles at this nanoparticle 
concentration. Fig. 1D shows the formation large 
agglomerations of ZnO nanoparticles on PCL 
fibers with 4 % w/w ZnO nanoparticle content. 
High surface energy of nanoparticles causes 
them to agglomerate together and this tendency 
is high at higher concentrations of nanoparticles 
(Wang et al., 2002).
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Microbial Barrier Property (MBP)
Microbial Barrier Property (MBP) was 
calculated from the Mueller Hinton Agar (MHA) 
plates which was spread plated with the peptone 
media from the sample bottles covered with the 
membranes as well as the negative control without 
any coverage. Microbes penetrated through 
the membranes into the media were multiplied 
there and these bacteria could produce colony 
forming units in the MHA plates. Here, the MBP 
is expressed as the ability of the membrane to 
prevent the microbial invasion in percentage 
compared to a control. The positive control can be 
any standard dressing material or bandage which 
is commonly used for the applications similar to 
the application of the newly developed material. 
Resulting MBP with reference to positive control 
is given in Table 1. Here, Cipla 1st AID has taken 
as the positive control. While calculating the 
MBP with reference to positive control, neat PCL 
membrane had shown to have 95 % MBP. Since 
the pore size is the major factor that affect the 
MBP, PCL/ZnO nanocomposite membranes have 
also shown comparable MBP (with an average 
MBP of 95.6 ± 0.89 %).
The evaluation of microbial barrier property 
of PCL/ZnO nanocomposite scaffolds showed 
that all the scaffolds showed very high bacterial 
barrier property irrespective of ZnO nanoparticle 
content. Thus, these scaffolds can be used as 
potential skin substitutes for preventing the entry 
of the microorganisms to wounds.
Blood cell aggregation studies
Tissue engineering scaffolds, wound 
dressings and skin substitutes are in direct 
Fig. 1. Scanning Electron Micrograph of electrospun neat PCL scaffold (A) and PCL scaffolds 
with 1% w/w ZnO nanoparticles (B). (C) and (D) are the high resolution SEM images of PCL 
scaffolds containing 1% and 4% w/w ZnO nanoparticles respectively. 
A  B
C  D
Fig. 1. Scanning Electron Micrograph of electrospun neat PCL scaffold (A) and PCL scaffolds with 1 % w/w ZnO 
nanoparticles (B). (C) and (D) are the high resolution SEM images of PCL scaffolds containing 1 % and 4 % w/w 
ZnO nanoparticles respectively
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contact with the blood at the application site. A 
material that causes aggregation of blood cells, 
especially RBC and WBC cannot be used for 
such blood contact applications. Since the PCL/
ZnO nanocomposite membranes are intended 
to be used as skin substitute materials, it is 
important to study the aggregation of blood cells 
on interaction with them. The aggregations of the 
blood cells on interaction with materials released 
from PCL/ZnO nanocomposite membranes are 
shown in Fig. 2 and Fig. 3, for RBC and WBC 
respectively. It confirmed that there was no 
aggregation of blood cells on incubation with 
any of the studied samples. Polyethyeleneimine 
(PEI) which was used as positive control showed 
aggregation whereas saline which was used as 
negative control did not induce any aggregation. 
The obtained results were comparable with that 
of normal saline.
Thus, the electrospun PCL/ZnO 
nanocomposite membranes can be used for blood 
contact applications like skin substitutes.
Platelet activation
Hemostasis is a process which causes 
bleeding to stop. It is the first stage of wound 
healing. Platelet activation is considered as 
the initial step of blood coagulation. Within 
seconds of a blood vessel’s epithelial wall 
being disrupted, platelets begin to aggregate 
together and starts to spread (Boon, 1993). Many 
instances like use of vascular constructs, cardiac 
implants, the materials used should not elicit 
platelet aggregation. However, it is advisable 
Table 1. Microbial barrier property ( %) of PCL/ZnO nanocomposite membranes with reference to positive control 
(standard wound coverage material “Cipla FirstAid”)
Samples Microbial barrier property
Neat PCL membrane 95 ± 3
PCL/ZnO-1 96 ± 1
PCL/ZnO-2 95 ± 2
PCL/ZnO-4 97 ± 1
PCL/ZnO-6 95 ± 2
Fig. 2. Aggregation of RBC due to neat PCL membrane (a), 1 wt% (b), 2 wt% (c) and 6 wt% (d) 
ZnO nanoparticles containing PCL membranes. (e) and (f) represents RBC aggregation in 
negative and positive controls respectively. 
Fig. 2. Aggregation of RBC due to neat PCL membrane (a), 1 % w/w (b), 2 % w/w (c) and 6 % w/w (d) ZnO 
nanoparticles containing PCL membranes. (e) and (f) represents RBC aggregation in negative and positive 
controls respectively
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Fig. 3. Aggregation of WBC due to neat PCL membrane (a), 1 wt% (b), 2 wt% (c) and 6 wt% (d) 
ZnO nanoparticles containing PCL membranes. (e) and (f) represents WBC aggregation in 
negative and positive controls respectively. 
Fig. 3. Aggregation of WBC due to neat PCL membrane (a), 1 % w/w (b), 2 % w/w (c) and 6% w/w (d) ZnO 
nanoparticles containing PCL membranes. (e) and (f) represents WBC aggregation in negative and positive 
controls respectively
to have hemostatic property for materials like 
wound dressings and skin substitutes to initiate 
coagulation to avoid excessive bleeding (Ulsh et 
al., 2013).
From Fig. 4, it is evident that platelets treated 
with PCL/ZnO nanocomposite membranes have 
shown platelet activation. Neat PCL membranes 
and PCL/ZnO-0.5 membranes did not show any 
sign of platelet activation. PCL membranes with 
ZnO nanoparticle concentrations of 1 % w/w and 
above showed platelet activation. In such cases, 
platelets aggregated together as clumps and spread 
in a circular manner. Platelet plug formation 
is an important event in hemostasis, platelets 
stick together to form a temporary seal to cover 
the break in the vessel wall. They allow for the 
creation of the “platelet plug” that forms almost 
soon after a blood vessel has been ruptured.
Reactive oxygen species are known to induce 
platelet activation and subsequent aggregation 
(Forde et al., 1997). The reactive oxygen species 
generated by ZnO nanoparticles might have 
enhanced the platelet aggregation. Thus, PCL/
ZnO nanocomposite membranes were able to 
induce coagulation by platelet activation and 
can act as effective hemostatic wound coverage 
materials.
Hemolysis test
Another important property to be tested 
to demonstrate the blood compatibility of 
biomedical materials is the hemolysis due to the 
material. It is well-known that red blood cells 
lyses when they come in contact with certain 
materials including water. Hemocompatibilty has 
been calculated with respect to a negative control 
(Normal saline-assumed as 0 % hemolytic) 
and a positive control (Double distilled water- 
assumed as 100 % hemolytic). According to 
ASTM standards, 1 % is the acceptable limit 
of hemolysis (ASTM Standard, F756-08). The 
hemolysis test results of the PCL membranes 
and PCL/ZnO nanocomposite membranes are 
shown in Table 2. All the tested samples have 
shown less than 1 % hemolysis which indicates 
good hemocompatibility for all the membranes 
irrespective of ZnO nanoparticle concentration. 
Thus, these hemocompatible scaffolds can be 
used as skin substitutes which are in contact with 
blood.
Conclusion
The electrospun PCL/ZnO nanocomposite 
membranes have been fabricated by electrospinning 
technique and evaluated for the microbial barrier 
Table 2. Percentage of hemolysis due to the effect of PCL and PCL/ZnO nanocomposite membranes
Sample Hemolysis ( %)
Neat PCL 0.2 ± 0.02
PCL/ZnO-0.5 0.2 ± 0.05
PCL/ZnO-1 0.2 ± 0.08
PCL/ZnO-2 0.3 ± 0.02
PCL/ZnO-4 0.2 ± 0.06
PCL/ZnO-6 0.3 ± 0.04
Negative control 0
Positive control 100
Fig. 4. Platelet activation and spreading; platelets incubated with neat PCL membrane (a), 0.5 % w/w (b), 
1 % w/w (c), 2 % w/w (d), 4 % w/w (e) and 6 % w/w (f) ZnO nanoparticles containing PCL membranes. (g) and 
(h) represents platelets incubated with negative and positive controls respectively
Fig. 4. Platelet activation and spreading; platelets incubated with neat PCL e brane (a), 0.5 
wt% (b), 1 wt  (c), 2 wt% (d), 4 wt% (e) and 6 wt% (f) ZnO nanoparticles containing PCL 
membranes. (g) and (h) represents platelets incubated with negative and positive controls 
respectively.
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property and blood compatibility. PCL/ZnO 
nanocomposite membranes have shown good 
microbial barrier property which suggest the 
ability of the fabricated material to prevent the 
bacterial invasion at the implantation site. All the 
fabricated membranes have possessed excellent 
microbial barrier property, irrespective of the 
ZnO nanoparticle content. Though there was 
aggregation of platelets in the presence of PCL/
ZnO nanocomposite scaffolds containing more 
than 1 % w/w ZnO nanoparticles, both blood 
cell aggregation studies and hemolysis tests have 
demonstrated the blood compatibility of the PCL/
ZnO nanocomposite membranes.
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